Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2022 Earnings Call Transcript February 21, 2023
Operator: Ladies and gentlemen, thank you for standing by, and welcome. Please be advised that today’s conference call may be recorded. I would now like to hand the conference over to Tiffany Aldrich, Associate Director, Corporate Communications at Esperion. Please go ahead, Tiffany.
Tiffany Aldrich: Thank you. Good morning, and welcome to Esperion’s fourth quarter and full year 2022 financial...
